Daehlin L, Frugård J
Department of Surgery, University of Bergen, Norway.
Scand J Urol Nephrol. 1997 Feb;31(1):57-61. doi: 10.3109/00365599709070303.
We report on one-year results after transurethral microwave thermotherapy (TUMT) in patients with symptoms due to benign prostatic hyperplasia (BPH). The material consists of 91 cases, treated with the PRIMUS U + R device in a single, one-hour out-patient procedure. The International Prostate Symptom Score (I-PSS), S, fell from baseline 23 (17-27) to 12 (7-18.8), quality of life assessment, L, improved from 4 (3-5) to 2 (1-3) and peak urinary flow increased from 9.6 +/- 0.3 to 11.1 +/- 0.4 (ml/sec) after one year. No changes in postvoiding residuals were observed. Sixty five per cent of the patients were assessed as responders to the treatment. Complications were urinary retention and bacteriuria. Neither enlargement of prostate nor a prominent median lobe, seem to be predictors of subjective outcome. TUMT appears to be a safe and, in the majority of patients, effective measure to relieve symptoms due to BPH.
我们报告了经尿道微波热疗（TUMT）治疗良性前列腺增生（BPH）所致症状患者的一年结果。该研究资料包括91例患者，使用PRIMUS U + R设备在单次一小时门诊手术中进行治疗。国际前列腺症状评分（I-PSS），S，从基线的23（17 - 27）降至12（7 - 18.8），生活质量评估，L，从4（3 - 5）改善至2（1 - 3），一年后最大尿流率从9.6±0.3增加至11.1±0.4（ml/秒）。未观察到残余尿量的变化。65%的患者被评估为对治疗有反应。并发症为尿潴留和菌尿症。前列腺增大和中叶突出似乎都不是主观治疗结果的预测因素。TUMT似乎是一种安全的治疗方法，并且在大多数患者中是缓解BPH所致症状的有效措施。
